SR0454LRB100 12489 MST 25431 r


2    WHEREAS, Pediatric acute-onset neuropsychiatric syndrome
3(PANS) and pediatric autoimmune neuropsychiatric disorder
4associated with streptococcal infection (PANDAS) create the
5sudden onset of obsessive-compulsive disorder in children,
6causing previously healthy and emotionally adjusted children
7to experience severe anxiety and emotional disturbances; and
8    WHEREAS, Children with PANS and PANDAS tend to manifest
9some of the following symptoms: tics or other abnormal
10movements, severe separation anxiety, generalized anxiety,
11irritability, aggression, personality changes, ADHD, marked
12deterioration in learning and school performance, and
13developmental regression, including deterioration in
14handwriting; and
15    WHEREAS, PANS is broader than PANDAS as it includes not
16only disorders associated with a preceding infection, such as
17Mycoplasma Pneumoniae, Mono, Lyme, viruses, and more, but also
18acute onset non-infectious triggers, such as environmental
19factors and metabolic dysfunction; treatment plans similar to
20those for PANDAS should be attempted; and
21    WHEREAS, Children with PANS and PANDAS may experience
22moderate to dramatic improvement with antibiotics, steroids,



SR0454- 2 -LRB100 12489 MST 25431 r

1intravenous immunoglobulin treatment, or plasmapheresis; and
2    WHEREAS, Researchers at the National Institute of Mental
3Health, along with 13 Centers for Excellence throughout the
4country, are currently engaged in extensive research to
5elucidate the causes and develop further effective treatment
6options for PANS and PANDAS; and
7    WHEREAS, Researchers at Moleculera Labs at the University
8of Oklahoma have developed PANS and PANDAS blood testing
9procedures; and
10    WHEREAS, The expert members of the physicians specialty
11society, the PANDAS Physicians Network, have developed and
12published standard treatment methods; and
13    WHEREAS, The organization PANDAS/PANS Advocacy and Support
14strives to build public awareness, educate medical providers
15about the disorder and treatments for same, build support for
16legislation involving the disorder, and provide support and
17resources for families affected by PANDAS/PANS, in accordance
18with section 501(c)(3); and
19    WHEREAS, The actual number of children suffering from PANS
20and PANDAS has been estimated to be approximately one out of
21every 200 children in the United States; and



SR0454- 3 -LRB100 12489 MST 25431 r

1    WHEREAS, It is imperative that there be greater public
2awareness of this serious health issue; therefore, be it
4ASSEMBLY OF THE STATE OF ILLINOIS, that we designate the date
5of October 9 of 2017 and 2018 as PANS and PANDAS Awareness Day
6in the State of Illinois; and be it further
7    RESOLVED, That a suitable copy of this resolution be
8presented to Wendy Nawara, President of PANDAS/PANS Advocacy
9and Support of Illinois.